• About Nektar
  • Our Leadership
  • Corporate Giving
  • Locations
  • Contacts
• Pipeline
  • Pipeline Overview
  • Nektar Proprietary Products
  • Nektar Partnered Products
  • Drug Development Platforms
• Partners
  • Nektar Partners
• Investor Relations
  • Press Releases
  • Stock Information
  • Financial Events Calendar
  • Analyst Coverage
  • Annual and Financial Reports
  • Corporate Governance
  • Investor Contacts
  • FAQ
  • Investor Advisory
• Media Room
  • Lead Product Backgrounder
  • Press Releases
  • Press Kit
  • Media Contacts
• Information Center
  • Scientific & Partnering Events
  • Multimedia
  • Library
  • Email Alerts
• Careers
  • Life at Nektar
  • Career Opportunities
  • Recruitment Calendar
  • Summer Internships
  • Benefits
  • Recruiting Information
  • Nektar Employee Foundation

• Nektar Partners

A partial list of our partners include some of the world's top pharmaceutical and biotechnology companies.

• Bayer: NKTR-061 Inhaled Amikacin and Inhaleable Ciproflaxin
  
  
• Baxter International: Hemophilia products
  
  
• Amgen: Neulasta®
  
  
• Roche: PEGASYS®  Download (pdf) Case Study of PEGASYS® and Mircera
  
  
• Schering-Plough: PEG-INTRON^®
  
  
• Novartis: Tobramycin inhalation powder (TIP)
  
  
• OSI-Eyetech: Macugen®
  
  
• UCB Pharma: Cimzia™ and CDP 791
  
  
• Affymax: Hematide
  
  
• MAP Pharmaceuticals: Inhaled DHE